Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Award-Winning PHT Corporation Scientist Dr. Susan Dallabrida to Present Poster on ePRO for Multiple Myeloma at ESMO 2014 Congress


Print article Print article
© Business Wire 2014
2014-09-04 16:27:01 -

PHT Corporation : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. announced that Vice President of Clinical Science and Consulting Services Dr. Susan Dallabrida will present “Effective Use of Electronic Patient Reported Outcomes (ePRO) in Multiple Myeloma” at the ESMO 2014 Congress, 26-30 September in Madrid. PHT is the leading provider of technologies used to collect patient-driven eData : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. for clinical research.

The ESMO 2014 Congress is sponsored by the European Society for Medical Oncology, the leading European professional organisation representing medical oncologists.

The poster abstract will also be published in the ESMO 2014 Congress Abstract Book, a supplement to the official ESMO journal Annals of Oncology.

The poster was developed by members of the PHT Clinical Science Team : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. ,

with 100+ years of collective experience in ePROs and COAs.



- Susan M. Dallabrida PhD, Vice President, Clinical Science & Consulting – Dr. Dallabrida has over 21 years of experience as a senior scientist, consultant and leader in clinical research and development, trial design and strategy, and product development. She has significant regulatory experience for biologics and small molecules.


- Sarah Tressel Gary PhD, Senior Science Advisor – Dr. Gary has significant experience working with PRO development and validation studies, questionnaire design and working with developers of standardized instruments. She is experienced in migration studies including cognitive debriefing and usability testing in a number of therapeutic areas.

Learn more about the PHT Clinical Science Team: bit.ly/PHTCSC : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbit ..

Learn about the Effective Use, Analysis, and Best Practices for Collecting eCOA Data in Oncology Programs : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. in a new educational webinar, 10 September. Register here: www.phtcorp.com/About/News-Events/Upcoming-Events-Webinars/Webin .. : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. .


About PHT CorporationPHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enable clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 17+ regulatory approvals.
Visit phtcorp.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. for more information on PHT. Follow PHT on LinkedIn : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Flin .. , Facebook : cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fww .. , Twitter : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbit .. , Google+ : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbit .. and YouTube : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbit .. .

" title="http://cts.businesswire.com/ct/CT?id=bwnews&sty=20140904005808r1&sid=16929&distro=ftp\"/>" target="_blank" rel="nofollow">cts.businesswire.com/ct/CT?id=bwnews&sty=20140904005808r1&am ..

For PHT CorporationBrenda Nashawaty, 617-688-3253 brenda@nashawaty.com : mailto:brenda@nashawaty.com


Author:
Hossam Abdel-Kader
e-mail
Web: www.pr-inside.com/
Phone: +43 1 9582319

Disclaimer: (c) 2014 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com